How should I evaluate and manage a patient who presents with facial numbness?

Evaluation and Management of Facial Numbness

Order MRI with contrast covering the entire trigeminal nerve course from brainstem to peripheral branches as your initial imaging study for any patient presenting with facial numbness. 1, 2

Initial Clinical Assessment

Distinguish Between Trigeminal Neuralgia vs. Neuropathy

The presence of facial numbness immediately indicates trigeminal neuropathy, not neuralgia—this distinction is critical and changes your entire diagnostic approach 3:

• Trigeminal neuralgia presents with paroxysmal, shock-like pain lasting seconds to minutes with complete pain-free intervals and no sensory deficits 1, 3
• Trigeminal neuropathy manifests with constant or intermittent pain plus demonstrable sensory or motor deficits such as facial numbness or weakness with mastication 1, 3
• Facial numbness is the hallmark of trigeminal neuropathy and represents destruction of primary sensory neurons 4

Critical Red Flags Requiring Urgent Evaluation

Any facial numbness, especially if progressive, necessitates immediate investigation as it may represent the earliest manifestation of malignancy, autoimmune disease, or other dangerous pathology 4:

• Progressive numbness warrants periodic re-evaluation even years after presentation if no initial diagnosis is made 4
• Facial numbness with poor response to medical management should prompt evaluation for underlying systemic autoimmune diseases including mixed connective tissue disease, systemic sclerosis, or Sjögren's syndrome 5
• Consider internal carotid artery dissection when facial numbness occurs with severe neck/face pain, altered taste, or Horner syndrome 6
• Chronic inflammatory demyelinating polyradiculopathy can present initially with facial weakness and numbness 7

Map the Sensory Distribution

Document the precise anatomical distribution to localize the lesion 1, 8:

• V1 (ophthalmic): Forehead, upper eyelid, cornea
• V2 (maxillary): Midface, cheek, upper lip—exits via infraorbital foramen 8
• V3 (mandibular): Lower face, jaw, anterior two-thirds of tongue—provides motor innervation to muscles of mastication 1

Test light touch, pinprick, and temperature across all three divisions bilaterally to identify sensory deficits 3

Assess for Motor Involvement

Check for weakness with jaw opening/closing and lateral jaw movements, which indicates V3 motor involvement and suggests pathology affecting the motor nucleus or mandibular division 1

Imaging Strategy

First-Line Imaging: MRI with Contrast

The American College of Radiology establishes MRI with contrast as the mainstay for evaluating trigeminal neuropathy 1, 2:

• Pre- and post-contrast imaging is essential to identify and characterize causative lesions 1, 2
• Coverage must extend from brainstem to peripheral branches—this may require combining MRI head with MRI orbits, face, and neck depending on your institutional protocols 1, 2
• Thin-cut high-resolution sequences through the entire course of cranial nerve V are mandatory 1, 2
• IV contrast should not be skipped unless contraindicated, as enhancing lesions may be missed 2

Critical Pitfall to Avoid

Do not order MRI head alone—routine brain protocols inadequately evaluate the extracranial course of peripheral nerve branches 2. The trigeminal nerve can be affected anywhere along its extensive course from brainstem nuclei through cisternal, dural cave, cavernous, foraminal, and extracranial segments 2.

Complementary CT Imaging

Add CT without contrast to evaluate osseous integrity of skull base and neural foramina (supraorbital, infraorbital, foramen ovale, foramen spinosum), particularly relevant in traumatic injury 1, 2. However, standard CT head coverage is insufficient to evaluate the full extent of trigeminal nerve divisions in the face 1.

Differential Diagnosis by Location

The trigeminal nerve can be affected by processes anywhere along its course 1:

Brainstem Lesions

• Multiple sclerosis (most common cause of secondary trigeminal neuralgia) 1
• Infarction, hemorrhage 1
• Vascular lesions: compressing vascular loops, aneurysms, vertebrobasilar dolichoectasia 1
• Inflammatory/infectious: meningitis, encephalitis, sarcoidosis 1
• Tumors: gliomas, lymphomas, metastases 1

Cisternal, Dural Cave, Cavernous, and Foraminal Segments

• Tumors (benign or malignant) 1
• Perineural spread of malignancy 1
• Vascular lesions 1
• Inflammatory processes 1

Peripheral Branches

• Perineural tumor spread affecting pterygopalatine fossa, orbit, skull base, or masticator space 1
• Trauma 2

Management Approach

When Imaging Identifies a Structural Lesion

Treatment targets the underlying cause:

• Tumors require neurosurgical or oncologic consultation
• Demyelinating disease requires neurology referral and disease-modifying therapy
• Vascular compression may warrant microvascular decompression 1

When No Structural Lesion is Found

Continue vigilant follow-up as dangerous pathology may not be apparent initially 4:

• Repeat imaging if symptoms progress 4
• Consider autoimmune workup if clinical features suggest connective tissue disease 5
• Blink reflexes may be useful to assess for peripheral nerve demyelination in suspected inflammatory neuropathy 7

Symptomatic Management

For neuropathic pain associated with trigeminal neuropathy:

• Carbamazepine remains first-line, though oxcarbazepine has fewer side effects 1
• Alternative agents include lamotrigine, baclofen, gabapentin, or pregabalin 1
• Tricyclic antidepressants may be effective 1

Key Takeaway

Facial numbness mandates comprehensive imaging of the entire trigeminal nerve pathway with MRI and contrast to exclude life-threatening causes including malignancy, stroke, demyelinating disease, and vascular pathology. 1, 2, 4 The presence of sensory deficits distinguishes neuropathy from neuralgia and fundamentally changes both diagnostic workup and treatment approach 3.